CBIO
Crescent Biopharma
CBIO
CBIO
35 hedge funds and large institutions have $15.8M invested in Crescent Biopharma in 2022 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 13 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
70% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 10
Holders
35
Holding in Top 10
–
Calls
$37K
Puts
–
Top Buyers
| 1 | +$57.3K | |
| 2 | +$37K | |
| 3 | +$19K | |
| 4 |
Millennium Management
New York
|
+$18.2K |
| 5 |
Jane Street
New York
|
+$11K |
Top Sellers
| 1 | -$309K | |
| 2 | -$125K | |
| 3 | -$103K | |
| 4 |
PVI
Pura Vida Investments
New York
|
-$100K |
| 5 |
BlackRock
New York
|
-$59.7K |